Total Payments
$946.80
2024 Payments
$137.98
Companies
12
Transactions
43
Payment Breakdown by Category
Food & Beverage$946.80 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $946.80 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $419.14 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $155.53 | 10 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83.08 | 4 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $55.69 | 3 | $0 (2019) |
| Eisai Inc. | $45.99 | 2 | $0 (2024) |
| Novo Nordisk Inc | $43.71 | 3 | $0 (2024) |
| Mission Pharmacal Company | $41.58 | 3 | $0 (2020) |
| Dexcom, Inc. | $26.71 | 1 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $20.07 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $19.05 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.98 | 6 | AstraZeneca Pharmaceuticals LP ($52.29) |
| 2023 | $17.87 | 1 | AstraZeneca Pharmaceuticals LP ($17.87) |
| 2022 | $101.60 | 1 | AstraZeneca Pharmaceuticals LP ($101.60) |
| 2021 | $71.33 | 4 | Novo Nordisk Inc ($29.59) |
| 2020 | $152.31 | 8 | AstraZeneca Pharmaceuticals LP ($62.93) |
| 2019 | $71.70 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($24.23) |
| 2018 | $100.17 | 7 | Janssen Pharmaceuticals, Inc ($49.66) |
| 2017 | $293.84 | 12 | AstraZeneca Pharmaceuticals LP ($184.45) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Endocrinology | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Hematology | ||||||
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Neurology | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/22/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $101.60 | General |
| Category: Rare Disease | ||||||
| 11/11/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Diabetes | ||||||
| 10/08/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Diabetes | ||||||
| 09/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: DIABETES | ||||||
| 07/16/2021 | Eisai Inc. | Aduhelm (Drug) | Food and Beverage | Cash or cash equivalent | $21.20 | General |
| Category: Neurology | ||||||
| 10/14/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/13/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: DIABETES | ||||||
| 10/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/15/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: DIABETES | ||||||
| 03/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2020 | Mission Pharmacal Company | Ferralet 90 (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Hematinic | ||||||
| 09/10/2019 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Allergy/Immunology | ||||||
| 08/04/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: DIABETES | ||||||
| 03/28/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: GASTROENTEROLOGY | ||||||
About Dr. Christopher Smith, D.O
Dr. Christopher Smith, D.O is a Dermatology healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1366681892.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Smith, D.O has received a total of $946.80 in payments from pharmaceutical and medical device companies, with $137.98 received in 2024. These payments were reported across 43 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($946.80).
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Family Medicine, Family Medicine
- Location Lauderhill, FL
- Active Since 02/06/2009
- Last Updated 11/28/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1366681892
Products in Payments
- FARXIGA (Drug) $192.55
- BYDUREON (Drug) $124.99
- ANDEXXA (Biological) $101.60
- XARELTO (Drug) $100.66
- JARDIANCE (Drug) $83.08
- XIFAXAN (Drug) $55.69
- INVOKANA (Drug) $54.87
- RYBELSUS (Drug) $29.59
- Dexcom G6 Transmitter (Medical Supply) $26.71
- Leqembi (Drug) $24.79
- Uribel (Drug) $21.64
- Aduhelm (Drug) $21.20
- ACCRUFER (Drug) $20.07
- Ferralet 90 (Drug) $19.94
- ELIQUIS (Drug) $19.05
- JANUVIA (Drug) $19.02
- ImmunoCAP (Device) $17.23
- Ozempic (Drug) $14.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.